Blood test to diagnose ALS using P2X4 markers
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at a protein called P2X4 on immune cells in your blood to see if it can help diagnose ALS. You would give a blood sample to help researchers find a new way to identify ALS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ALS that is 'probable' or 'confirmed' by your doctor.
- You are 18 years or older.
- You are covered by a social security plan.
- You can give signed permission (or a family member can give it for you).
- You are not taking drugs that suppress your immune system or corticosteroids.
- You are not currently in another study with an experimental treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood platelets (tiny cells that help with clotting) in people with ALS and other motor neuron diseases. It aims to find new markers that could help diagnose ALS earlier. If you have a recent diagnosis, you may be able to join by giving a blood sample.
This study collects samples (blood, skin, urine) from people with ALS to create cell banks and find biomarkers. It helps researchers learn more about the disease and may lead to better treatments.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
This study looks for biological markers in the blood or other samples to track how ALS progresses over time. The goal is to catch changes earlier, which could help in future treatments.
This study is looking for people with ALS to help doctors understand how certain biological markers (biomarkers) change over time. It involves a lumbar puncture (spinal tap) to collect fluid from your spine and regular check-ups.
This trial studies the “innate immune system” (your body’s first-line immune response) in people with ALS and in comparison groups. It may help researchers understand what drives ALS and how immune changes could relate to symptoms.
Hear when a new Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.